BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34987650)

  • 21. Glioblastoma Associated Natural Killer Cell EVs Generating Tumour-Specific Signatures: Noninvasive GBM Liquid Biopsy with Self-Functionalized Quantum Probes.
    Ishwar D; Haldavnekar R; Das S; Tan B; Venkatakrishnan K
    ACS Nano; 2022 Jul; 16(7):10859-10877. PubMed ID: 35816089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acoustic cavitation-based monitoring of the reversibility and permeability of ultrasound-induced blood-brain barrier opening.
    Sun T; Samiotaki G; Wang S; Acosta C; Chen CC; Konofagou EE
    Phys Med Biol; 2015 Dec; 60(23):9079-94. PubMed ID: 26562661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
    Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
    Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives.
    Gatto L; Franceschi E; Di Nunno V; Tosoni A; Lodi R; Brandes AA
    Oncologist; 2021 Oct; 26(10):865-878. PubMed ID: 34105205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
    Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas.
    Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D
    BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficiency of drug delivery enhanced by acoustic pressure during blood-brain barrier disruption induced by focused ultrasound.
    Yang FY; Lee PY
    Int J Nanomedicine; 2012; 7():2573-82. PubMed ID: 22679368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.
    Park EJ; Zhang YZ; Vykhodtseva N; McDannold N
    J Control Release; 2012 Nov; 163(3):277-84. PubMed ID: 23000189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Crosstalk between T Cells and Tumor Uncovers GBM-Specific T Cell Signatures in Blood: Noninvasive GBM Diagnosis Using Immunosensors.
    Dhinakaran AK; Dharmalingam P; Ganesh S; Venkatakrishnan K; Das S; Tan B
    ACS Nano; 2022 Sep; 16(9):14134-14148. PubMed ID: 36040842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiling of the immune landscape in murine glioblastoma following blood brain/tumor barrier disruption with MR image-guided focused ultrasound.
    Sheybani ND; Witter AR; Garrison WJ; Miller GW; Price RJ; Bullock TNJ
    J Neurooncol; 2022 Jan; 156(1):109-122. PubMed ID: 34734364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments.
    Poon C; Pellow C; Hynynen K
    Theranostics; 2021; 11(4):1655-1671. PubMed ID: 33408773
    [No Abstract]   [Full Text] [Related]  

  • 32. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.
    Eskilsson E; Rosland GV; Talasila KM; Knappskog S; Keunen O; Sottoriva A; Foerster S; Solecki G; Taxt T; Jirik R; Fritah S; Harter PN; Välk K; Al Hossain J; Joseph JV; Jahedi R; Saed HS; Piccirillo SG; Spiteri I; Leiss L; Euskirchen P; Graziani G; Daubon T; Lund-Johansen M; Enger PØ; Winkler F; Ritter CA; Niclou SP; Watts C; Bjerkvig R; Miletic H
    Neuro Oncol; 2016 Dec; 18(12):1644-1655. PubMed ID: 27286795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Liquid Biopsy Using Irradiation to Facilitate the Release of Cell-Free DNA from a Spatially Aimed Tumor Tissue.
    Noh JM; Kim YJ; Lee HY; Choi C; Ahn WG; Lee T; Pyo H; Park JH; Park D; Park WY
    Cancer Res Treat; 2022 Jan; 54(1):40-53. PubMed ID: 34044476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
    Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
    J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models.
    Mair R; Mouliere F; Smith CG; Chandrananda D; Gale D; Marass F; Tsui DWY; Massie CE; Wright AJ; Watts C; Rosenfeld N; Brindle KM
    Cancer Res; 2019 Jan; 79(1):220-230. PubMed ID: 30389699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy.
    Panditharatna E; Kilburn LB; Aboian MS; Kambhampati M; Gordish-Dressman H; Magge SN; Gupta N; Myseros JS; Hwang EI; Kline C; Crawford JR; Warren KE; Cha S; Liang WS; Berens ME; Packer RJ; Resnick AC; Prados M; Mueller S; Nazarian J
    Clin Cancer Res; 2018 Dec; 24(23):5850-5859. PubMed ID: 30322880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applications of Focused Ultrasound for the Treatment of Glioblastoma: A New Frontier.
    Hersh AM; Bhimreddy M; Weber-Levine C; Jiang K; Alomari S; Theodore N; Manbachi A; Tyler BM
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localized blood-brain barrier opening in infiltrating gliomas with MRI-guided acoustic emissions-controlled focused ultrasound.
    Anastasiadis P; Gandhi D; Guo Y; Ahmed AK; Bentzen SM; Arvanitis C; Woodworth GF
    Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34504017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of transient increase of the blood-brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles.
    Shi L; Palacio-Mancheno P; Badami J; Shin DW; Zeng M; Cardoso L; Tu R; Fu BM
    Int J Nanomedicine; 2014; 9():4437-48. PubMed ID: 25258533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.
    Park J; Zhang Y; Vykhodtseva N; Jolesz FA; McDannold NJ
    J Control Release; 2012 Aug; 162(1):134-42. PubMed ID: 22709590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.